Cartesian Therapeutics ($RNAC)

Description

Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients with autoimmune disorders.

Related

• Artiva Biotherapeutics ($ARTV)Develops off-the-shelf, non-genetically modified natural killer cell therapies for deep B-cell depletion, aiming to help patients with…
• Kyverna Therapeutics (San Diego)Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing…
• Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…
• Century TherapeuticsDevelops off-the-shelf cell therapy candidates from induced pluripotent stem cells for patients with autoimmune conditions, including type…
• Vor BiopharmaDevelops telitacicept, a BAFF/APRIL inhibitor for autoimmune diseases, aiming to rebalance immunity by blocking survival signals for…
• Cabaletta Bio ($CABA)Develops engineered T cell therapies for autoimmune diseases, including rese-cel in Phase 1/2 trials for lupus, myositis, systemic…
• Life BiosciencesDevelops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial…
• March BiosciencesDevelops clinical-stage CAR-T cell therapies, including MB-105, aimed at difficult hematological cancers, with a focus on relapsed or…
• Kyverna Therapeutics ($KYTX)Develops CAR T-cell therapies for autoimmune diseases, with clinical trials addressing conditions including stiff person syndrome and…
• bluebird bioDevelops one-time gene addition treatments for rare hematologic diseases, using patients' own cells and patient support services to help…
• BioNTechBioNTech develops investigational therapies for cancer and infectious diseases, including mRNA cancer immunotherapies, immunomodulators,…
• Aspen NeuroscienceDevelops autologous iPSC-derived cell therapies using a patient’s own cells, initially targeting Parkinson’s disease by replacing lost…